bpc-157 synthetic pentadecapeptide gastric juice BPC 157 | | 137525-51-0 BPC-157 Peptide | BPC-157 Synthetic

5--1MQ ,

Most BPC-157 preclinical work uses dosages around 10 mcg/kg administered intraperitoneally or subcutaneously in rodents, with study durations ranging from single administration to 14-day periods

BPC157 solution for administration was prepared by diluting the required amount of concentrated BPC157 solution in 0.9% NaCl injection solution prior to administration

Elevated GH and IGF-1 promote protein synthesis, cell proliferation, tissue remodeling across all body systems including musculoskeletal

Unlike most peptides, which are rapidly degraded by stomach acid and digestive enzymes, BPC-157 is derived from a protein naturally present in human gastric juice and has demonstrated remarkable resistance to enzymatic hydrolysis in gastric conditions